“Elanco stock is up 39% over the past year, reaching a 52-week high earlier this week and significantly outperforming its peers.” In a letter to employees the same day, he wrote in tight prose ...

Welcome to Elanco Animal Health's fourth quarter 2024 earnings conference call. (Operator Instructions) Thank you. I woulrd now like to hand the call over to Tiffany Kanaga, Head of Investor ...

Elanco is down 4.4% since the beginning of the year, and at $11.51 per share, it is trading 37.6% below its 52-week high of $18.45 from June 2024.

NORTHAMPTON, MA / ACCESS Newswire / April 8, 2025 / At Elanco, our commitment to animal health goes beyond developing innovative products and extends to supporting the organisations that make a ...

We think Elanco’s recent acquisitions in the companion animal space have taken a toll on the company’s financial strength. To close the Bayer Animal Health acquisition, the company more than ...

Elanco Animal Health Incorporated (NYSE:ELAN) Q4 2024 Earnings Call Transcript February 25, 2025 Elanco Animal Health Incorporated misses on earnings expectations. Reported EPS is $0.14 EPS ...

Elanco Animal Health (NYSE:ELAN) is an interesting case study - at least for me.And it is a stock that demonstrated how important it is to have a solid investment thesis based on fundamentals and ...

Elanco faces pressure from pipeline delays and Bayer-related debt, with modest growth and falling EBITDA. See why ELAN stock is a hold.

However, Elanco and rival Zoetis’ overall weighted average cost of capital in our models is the same at 8.6%, which reflects Elanco’s greater reliance on debt.

Elanco, currently based in Greenfield, ... “There are many things going right in the city—I want everyone to know that and hear that from me,” Simmons told more than 300 luncheon attendees.

Elanco has also announced plans to begin declassifying the board, providing shareholders the right to amend the bylaws and enabling them, under certain circumstances, to call special meetings.